Vitamin B12 Shows Promise in Reversing Verheij Syndrome Effects

New research indicates that vitamin B12 may reverse developmental issues linked to Verheij syndrome in laboratory models.

A
Aapla Nagpur Desk
16 Nov 2026, 8:17 PM IST · 2 min read
Source: Sciencedaily
Vitamin B12 Shows Promise in Reversing Verheij Syndrome Effects
KEY TAKEAWAYS
1

Vitamin B12 corrected growth abnormalities in C. elegans with a mutation linked to Verheij syndrome.

2

Similar metabolic disruptions were found in human patients, suggesting potential treatment avenues.

3

Further studies are needed to explore the efficacy of vitamin B12 supplementation in humans.

A recent study conducted by researchers at the Max Planck Institute for Biology of Ageing has revealed that vitamin B12 may play a crucial role in addressing developmental issues associated with Verheij syndrome, a rare genetic disorder. The findings, published on November 16, 2026, highlight how this common vitamin can reverse abnormalities observed in laboratory models, specifically in C. elegans, a type of roundworm used extensively in biological research.

Verheij syndrome is characterized by growth delays and developmental challenges, often stemming from mutations in genes responsible for RNA splicing. This cellular process is vital for producing proteins, as it involves the removal of unnecessary RNA segments and the joining of essential ones. Disruptions in RNA splicing can lead to significant developmental disorders, prompting researchers to investigate how these genetic mutations affect growth and metabolism.

In their experiments, the researchers focused on a specific mutation in a gene linked to RNA splicing. They discovered that worms with this mutation exhibited growth issues similar to those seen in humans with Verheij syndrome. Further analysis revealed that the mutation interfered with metabolic pathways reliant on vitamin B12, which are critical for normal growth and cellular functions. Remarkably, when the worms were given additional vitamin B12, the metabolic processes were restored, and their developmental defects were largely corrected.

To assess the relevance of these findings to humans, the team examined data from human cells and collaborated with a neuropediatrician to analyze blood samples from patients diagnosed with Verheij syndrome. The results indicated that similar metabolic disruptions were present in these patients, raising the possibility that vitamin B12 could also benefit individuals suffering from this disorder. However, the researchers caution that more studies are needed to determine whether vitamin B12 supplementation can effectively alleviate symptoms in humans.

This discovery not only offers hope for treating Verheij syndrome but also suggests that metabolic disruptions may play a more significant role in other genetic disorders caused by faulty RNA splicing. Understanding these connections could lead to new therapeutic strategies, potentially benefiting a broader range of rare genetic conditions. As noted by Adam Antebi, the study's lead author, this research exemplifies how insights gained from model organisms can inform our understanding of human diseases, paving the way for future medical advancements.

💬What did you think of this story?What did you think?

Read Next

Vitamin B12 and Verheij Syndrome Research